PROM1 and metabolic dysfunction-associated steatotic liver disease: CD133 + Exo treatment significantly improves neurocognitive function, vascular and white matter remodeling in the ischemic brain as well as attenuates the progression of NAFLD/NASH in the liver of T2DM stroke mice.